AskVantage

Nula Therapeutics

Nula Therapeutics is a startup headquartered in St. Petersburg, United States, founded in 2021. It has raised at least $7.4m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.

Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .

2021Founded
StartupStage
St. Petersburg, United StatesHeadquarters
BiotechnologyIndustry
$7.4m+Raised (SEC filings)
EarlyFunding stage
Biotechnology
See it on the interactive mapBook a Briefing

Funding

Nula Therapeutics has raised at least $7.4m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

R&D ecosystem

Nula Therapeutics sits inside the St. Petersburg region R&D ecosystem in the Global R&D Labs Directory.

Other startups in St. Petersburg

Related

Questions and answers

What does Nula Therapeutics do?

Nula Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.

How much has Nula Therapeutics raised?

At least $7.4m, according to its Form D filings with the US Securities and Exchange Commission.

Where is Nula Therapeutics based?

Nula Therapeutics is headquartered in St. Petersburg, United States.

When was Nula Therapeutics founded?

Nula Therapeutics was founded in 2021.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.